Associations with visual acuity outcomes after 12 months of treatment in 9401 eyes with neovascular AMD

• ,
• Martin McKibbin,
• Andrew Lotery,
• C Brand,
• C Bailey,
• C Santiago,
• L Downey,
• I Pearce,
• B Mushtaq,
• H Devonport,
• I Dias,
• RM West,
• SD Relton,
• GC Chi,
• P Scanlon,
• H Saedon,
• SJ Talks

Affiliations

1Melbourne Sexual Health Centre, Alfred Health, Carlton, Australia

Martin McKibbin

specialist registrar in ophthalmology

Andrew Lotery

3 Department of Clinical and Experimental Sciences, University of Southampton, Southampton, UK

C Brand

3Royal Hospital for Sick Children Edinburgh, NHS Lothian, Edinburgh, UK

C Bailey

3University Hospital Coventry & Warwickshire, Coventry, UK

C Santiago

Universidad Europea de Madrid, Spain

L Downey

4Hull and East Yorkshire Eye Hospital, Kingston upon Hull, UK

I Pearce

St Paul’s Eye Unit, Royal Liverpool University Hospital and Unit of Ophthalmology, University of Liverpool, UK

B Mushtaq

Birmingham and Midland Eye Centre, Birmingham, UK

H Devonport

Uveitis Service, Department of Ophthalmology, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK

I Dias

Department of Civil Engineering, University of Moratuwa, Sri Lanka

RM West

University of Leeds, Leeds, UK

SD Relton

Faculty of Medicine and Health, University of Leeds, Leeds, UK

GC Chi

Genentech Inc, South San Francisco, California, USA

P Scanlon

H Saedon

SJ Talks